Associations of disordered eating with the intestinal microbiota and short-chain fatty acids among young adults with type 1 diabetes

Nutrition, metabolism, and cardiovascular diseases : NMCD(2023)

引用 0|浏览10
暂无评分
摘要
Background and aims: Disordered eating (DE) in type 1 diabetes (T1D) includes insulin restriction for weight loss with serious complications. Gut microbiota-derived short chain fatty acids (SCFA) may benefit host metabolism but are reduced in T1D. We evaluated the hypothesis that DE and insulin restriction were associated with reduced SCFA-producing gut microbes, SCFA, and intestinal microbial diversity in adults with T1D. Methods and results: We collected stool samples at four timepoints in a hypothesis-generating gut microbiome pilot study ancillary to a weight management pilot in young adults with T1D. 16S ribosomal RNA gene sequencing measured the normalized abundance of SCFA-producing in-testinal microbes. Gas-chromatography mass-spectrometry measured SCFA (total, acetate, buty-rate, and propionate). The Diabetes Eating Problem SurveydRevised (DEPS-R) assessed DE and insulin restriction. Covariate-adjusted and Bonferroni-corrected generalized estimating equa-tions modeled the associations. COVID-19 interrupted data collection, so models were repeated restricted to pre-COVID-19 data. Data were available for 45 participants at 109 visits, which included 42 participants at 65 visits pre-COVID-19. Participants reported restricting insulin "At least sometimes" at 53.3% of visits. Pre-COVID-19, each 5-point DEPS-R increase was associated with a-0.34 (95% CI-0.56,-0.13, p = 0.07) lower normalized abundance of genus Anaerostipes; and the normalized abundance of Lachnospira genus was-0.94 (95% CI-1.5,-0.42), p = 0.02 lower when insulin restriction was reported "At least sometimes" compared to "Rarely or Never".Conclusion: DE and insulin restriction were associated with a reduced abundance of SCFA-producing gut microbes pre-COVID-19. Additional studies are needed to confirm these associa-tions to inform microbiota-based therapies in T1D. 2022 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Ital-ian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
更多
查看译文
关键词
Disordered eating,Gut microbiota,Insulin restriction,Obesity,Short-chain fatty acids,Type 1 diabetes
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要